SEVERE COMMUNITY-ACQUIRED PNEUMONIA - ETIOLOGY, EPIDEMIOLOGY, AND PROGNOSIS FACTORS

被引:244
作者
MOINE, P [1 ]
VERCKEN, JB [1 ]
CHEVRET, S [1 ]
CHASTANG, C [1 ]
GAJDOS, P [1 ]
SCHLEMMER, B [1 ]
GARROUSTE, MT [1 ]
MUIR, JF [1 ]
DEFOUILLOY, C [1 ]
THALER, F [1 ]
TENAILLON, A [1 ]
CARLET, J [1 ]
TIMSIT, JF [1 ]
DEROHANCHABOT, P [1 ]
BOLES, JM [1 ]
OUTIN, H [1 ]
TEMPE, JD [1 ]
SCHNEIDER, F [1 ]
HOLZAPFEL, L [1 ]
SOLLET, JP [1 ]
PETITPRETZ, P [1 ]
FRAISSE, F [1 ]
GBIKPIBENISSIAN, G [1 ]
CARDINAUD, JP [1 ]
BRUNBUISSON, C [1 ]
机构
[1] HOP ST LOUIS, DEPT BIOSTAT & INFORMAT MED, PARIS, FRANCE
关键词
D O I
10.1378/chest.105.5.1487
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A prospective study of 132 patients with severe community-acquired pneumonia (CAP) treated in the ICU was carried out to determine the causative agents, the value of the clinical, biological, and radiologic features in predicting the etiology, and to define prognostic factors. The study group included 98 men and 34 women (mean age: 58 +/- 18 years). The most frequent underlying condition was COPD (51 patients, 39 percent). On admission, 35 patients were in shock, 71 were mentally confused, and 81 (61 percent) required mechanical ventilation during their hospitalization. The clinical, laboratory, and radiologic parameters were of little value for predicting the etiology in patients with severe CAP. An etiologic diagnosis was made in 95 (72 percent) patients. The most frequent pathogens were Streptococcus pneumoniae (43 cases [45 percent]), Gram-negative bacilli (14 cases [15 percent]), and Haemophilus influenzae (14 cases [15 percent]) Mortality was 24 percent. It was significantly associated with a age more than 60 years, septic shock, impairment of alertness, mechanical ventilation requirement, bacteremic pneumonia, and S pneumoniae or Enterobacteriaceae as the causes of the pneumonia. Recommendations for antibiotic chemotherapy in patients with severe CAP admitted to the ICU are included.
引用
收藏
页码:1487 / 1495
页数:9
相关论文
共 54 条
  • [1] BARTLETT JG, 1987, CLIN CHEST MED, V8, P119
  • [2] BARTLETT JG, 1977, AM REV RESPIR DIS, V115, P777
  • [3] Bartlett R C, 1970, Conn Med, V34, P347
  • [4] ESCHERICHIA-COLI PNEUMONIA IN THE ELDERLY - WITH REFERENCE TO THE ROLE OF ESCHERICHIA-COLI K1 CAPSULAR POLYSACCHARIDE ANTIGEN
    BERK, SL
    NEUMANN, P
    HOLTSCLAW, S
    SMITH, JK
    [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 72 (06) : 899 - 902
  • [5] ETIOLOGY OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS REQUIRING HOSPITALIZATION
    BERNTSSON, E
    BLOMBERG, J
    LAGERGARD, T
    TROLLFORS, B
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1985, 4 (03) : 268 - 272
  • [6] MYCOPLASMAS AS AGENTS OF HUMAN-DISEASE
    CASSELL, GH
    COLE, BC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (02) : 80 - 89
  • [7] CHASTRE J, 1984, AM REV RESPIR DIS, V130, P924
  • [8] A COMPARISON OF 3 SEVERITY SCORE INDEXES IN AN EVALUATION OF SERIOUS BACTERIAL PNEUMONIA
    DUROCHER, A
    SAULNIER, F
    BEUSCART, R
    DIEVART, F
    BART, F
    DETURCK, R
    WATTEL, F
    [J]. INTENSIVE CARE MEDICINE, 1988, 14 (01) : 39 - 43
  • [9] COMMUNITY-ACQUIRED BACTEREMIC PNEUMOCOCCAL PNEUMONIA - EFFECT OF AGE ON MANIFESTATIONS AND OUTCOME
    ESPOSITO, AL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (05) : 945 - 948
  • [10] NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES
    FANG, GD
    FINE, M
    ORLOFF, J
    ARISUMI, D
    YU, VL
    KAPOOR, W
    GRAYSTON, JT
    WANG, SP
    KOHLER, R
    MUDER, RR
    YEE, YC
    RIHS, JD
    VICKERS, RM
    [J]. MEDICINE, 1990, 69 (05) : 307 - 316